Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.
about
miR-451 protects against erythroid oxidant stress by repressing 14-3-3zetaMicroRNA-338-3p and microRNA-451 contribute to the formation of basolateral polarity in epithelial cellsInvestigative and extrapolative role of microRNAs' genetic expression in breast carcinomaTransferring intercellular signals and traits between cancer cells: extracellular vesicles as "homing pigeons"microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessmentChemoresistance, cancer stem cells, and miRNA influences: the case for neuroblastomaThe effects of microRNA on the absorption, distribution, metabolism and excretion of drugsMicroRNAs in breast cancer initiation and progressionNon-coding RNAs as theranostics in human cancersMechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNARole of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL)Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancerExosomes-mediate microRNAs transfer in breast cancer chemoresistance regulationDecoding the usefulness of non-coding RNAs as breast cancer markersApoptomiRs of Breast Cancer: Basics to ClinicsThe microRNA-200 family: small molecules with novel roles in cancer development, progression and therapymicroRNA involvement in human cancerHigh and low dose radiation effects on mammary adenocarcinoma cells - an epigenetic connectionHistone deacetylase inhibitors regulate P-gp expression in colorectal cancer via transcriptional activation and mRNA stabilizationCirculating MiR-125b as a marker predicting chemoresistance in breast cancermiR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expressionChanges in the expression of miR-381 and miR-495 are inversely associated with the expression of the MDR1 gene and development of multi-drug resistanceRegulation of multidrug resistance proteins by genistein in a hepatocarcinoma cell line: impact on sorafenib cytotoxicityMiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 CellsDifferent modalities of intercellular membrane exchanges mediate cell-to-cell p-glycoprotein transfers in MCF-7 breast cancer cells.A hierarchical poisson log-normal model for network inference from RNA sequencing data.Association between DNA methylation in the miR-328 5'-flanking region and inter-individual differences in miR-328 and BCRP expression in human placentaMicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol.MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma.MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment.Prediction of a gene regulatory network linked to prostate cancer from gene expression, microRNA and clinical data.Molecular characterization of aromatase inhibitor-resistant, tamoxifen-resistant and LTEDaro cell linesSelective release of microRNA species from normal and malignant mammary epithelial cells.PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation.The down-regulation of SLC7A11 enhances ROS induced P-gp over-expression and drug resistance in MCF-7 breast cancer cells.Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1.Implication of microRNAs in drug resistance for designing novel cancer therapy
P2860
Q24600133-8EA4EF74-6D6B-425C-8CE6-0AF77AC7D4C4Q24642812-74225FE9-1514-44A6-BCB9-5B2BB3A97FCDQ26744842-719D530E-3325-4407-A070-A205DFAE4A34Q26747281-E39406C7-CC50-4BCA-917F-8822CE10CED6Q26778918-6C9BBF28-0BDA-40A3-8147-3EE560D86196Q26800007-FF2AA75C-BE2D-4DBB-BEBE-A71F2EBFC1CBQ26822987-7F8BDEFB-5FB8-4A9F-B9DA-EA69B69822E3Q26823360-566A2B54-A3DE-409E-8325-19C80044C39DQ26851250-EBF292A7-D0C7-4F85-816A-67AE4068D0B1Q27011221-97237391-591D-45A6-9C81-78C474738588Q27016561-995C4BB5-09B2-428C-8390-4B78C715DA06Q28066481-604BF94D-6886-4D24-8732-0D4241D07C36Q28066991-BE65F5E6-BE80-47A4-933A-DC419B388A27Q28069370-48C058C8-9876-4DDF-8A1A-B05AA3F1EB73Q28072414-6BD0EB1B-A1D3-445B-A91F-F254E157A7EDQ28083742-437B3D5B-D5CD-4F34-A7C5-B87875940274Q28264087-DDF5753B-D357-4C34-896A-78F8B83C65E8Q28394677-0D48E6AA-B789-452C-8EA4-9D8C322E8ED1Q28468630-64896E89-EAAD-43AA-BAE8-DB8C10D9638DQ28482362-145390BB-EE75-44A2-91F7-F703D924314AQ28485384-B5ED3FE0-5425-44D7-9D30-A5B770373067Q28535423-A389F3F4-766D-4D1E-8CC0-BD0C0F0BAD67Q28544454-F2BB312A-BF6C-4A83-9C5D-FC79DB26FEFDQ28547840-3E751B30-6654-44F7-97DB-2D9FEF200635Q30506221-EEE19BAF-8A74-44FF-9853-9B9C576AD3BDQ30681834-677A0886-9F0C-4334-A5C0-CE6E8FC7300DQ31133417-B6CC7D1F-BC7B-44F4-86C1-EFB0FE90A1BAQ33527586-16237637-D5F3-40DA-BE23-2E58A4BAC27BQ33560283-084337E8-3464-4479-A49D-1E6BB9E63346Q33565049-F7301607-8EFB-4318-A91D-BFB02BCE1B31Q33585094-50D386DD-D9DC-4909-ACD8-2B08EA00F414Q33686676-2B34F1F0-46BC-4E60-BBDA-8DD02B247C1FQ33718304-4E50084D-14CC-40E3-81B3-351F952F7A41Q33728084-0F39FF54-C678-4D71-9E6A-EC0EA530DE46Q33767159-38FA1302-7D4D-49CF-91F0-F6C2A4EBF660Q33812772-F1BEC592-E656-49E1-B274-9D60CF3A47BBQ33838622-3E1742E6-3D43-4483-932C-4B722F9EF2AEQ33850064-7CED48ED-9C28-4E75-926B-4EB1269E5671Q33891809-89CD8F7A-BC77-43E7-811C-996BD6638EC7Q33903223-A12DAD7B-F2FE-49CD-BF0F-4CD0B30ADB90
P2860
Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Involvement of microRNA-451 in ...... otherapeutic drug doxorubicin.
@ast
Involvement of microRNA-451 in ...... otherapeutic drug doxorubicin.
@en
Involvement of microRNA-451 in ...... otherapeutic drug doxorubicin.
@nl
type
label
Involvement of microRNA-451 in ...... otherapeutic drug doxorubicin.
@ast
Involvement of microRNA-451 in ...... otherapeutic drug doxorubicin.
@en
Involvement of microRNA-451 in ...... otherapeutic drug doxorubicin.
@nl
prefLabel
Involvement of microRNA-451 in ...... otherapeutic drug doxorubicin.
@ast
Involvement of microRNA-451 in ...... otherapeutic drug doxorubicin.
@en
Involvement of microRNA-451 in ...... otherapeutic drug doxorubicin.
@nl
P2093
P1476
Involvement of microRNA-451 in ...... motherapeutic drug doxorubicin
@en
P2093
Igor P Pogribny
James Meservy
Jody Filkowski
Olga Kovalchuk
Vasyl' F Chekhun
Yaroslav Ilnytskyy
P304
P356
10.1158/1535-7163.MCT-08-0021
P577
2008-07-01T00:00:00Z